col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Current Opinion in Virology
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―08 Structure of SARS-CoV-2 Spike Protein Jun Zhang, Tianshu Xiao, Yongfei Cai, Bing Chen
2 [GO] 2021―Aug―21 Know your enemy and know yourself - the case of SARS-CoV-2 host factors Wai Suet Lee, Meisam Yousefi, Biao Guo Yan, Cythia Lingli Yong, Yaw Shin Ooi
3 [GO] 2021―Aug―20 Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets Asmaa Hachim, Niloufar Kavian, Sophie A Valkenburg
4 [GO] 2021―Aug―17 Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19? Ivan Zanoni
5 [GO] 2021―Jul―24 Proteases and variants: context matters for SARS-CoV-2 entry assays Christian S Stevens, Kasopefoluwa Y Oguntuyo, Lee Benhur
6 [GO] 2021―Jul―13 COVID-19, the first pandemic in the post-genomic era Lucy van Dorp, Charlotte J Houldcroft, Damien Richard, François Balloux
7 [GO] 2021―Jun―29 Time to “Mind the Gap” in Novel Small Molecule Drug Discovery for Direct-Acting Antivirals for SARS-CoV-2 Colleen B Jonsson, Jennifer E Golden, Bernd Meibohm
8 [GO] 2021―Jun―29 Animal models of SARS-CoV-2 transmission Rory D de Vries, Barry Rockx, Bart L Haagmans, Sander Herfst, Marion PG Koopmans, Rik L de Swart
9 [GO] 2021―Jun―19 Natural killer cells and unconventional T cells in COVID-19 Niklas K Björkström, Andrea Ponzetta
10 [GO] 2021―Jun―19 Progress and pitfalls of a year of drug repurposing screens against COVID-19 Julien Sourimant, Megha Aggarwal, Richard K Plemper
11 [GO] 2021―Jun―18 Developing A Direct Acting, Orally Available Antiviral Agent in a Pandemic: The Evolution of Molnupiravir as a Potential Treatment for COVID-19 George R Painter, Michael G Natchus, Oren Cohen, Wendy Holman, Wendy P Painter
12 [GO] 2021―Jun―03 The impact of high-resolution structural data on stemming the COVID-19 pandemic Robert M Cox, Richard K Plemper
13 [GO] 2021―May―12 Remdesivir for the Treatment of Covid-19: The Value of Biochemical Studies Götte Matthias
14 [GO] 2021―May―04 SARS-CoV-2 vaccines - The biggest medical research project of the 21st century Drishya Kurup, Matthias J Schnell
15 [GO] 2021―Apr―27 Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection Koen Vandyck, Jerome Deval
16 [GO] 2021―Apr―21 Microbiota as a potentially-modifiable factor influencing COVID-19 Vu L Ngo, Andrew T Gewirtz
17 [GO] 2021―Apr―06 Structure and function of SARS-CoV-2 polymerase Hauke S Hillen
18 [GO] 2021―Apr―06 Animal Models for SARS-CoV-2 Chung-Young Lee, Anice C Lowen
19 [GO] 2021―Mar―10 Coronavirus entry: how we arrived at SARS-CoV-2 Gary R Whittaker, Susan Daniel, Jean K Millet
20 [GO] 2020―Sep―10 Editorial overview: Combating measles during a COVID-19 pandemic Rik L de Swart, Makoto Takeda
21 [GO] 2020―Jun―04 The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health Timothy P Sheahan, Matthew B Frieman


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.009 sec